Revvity Inc vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? Revvity Inc trades at $110.1 (market cap $11.87B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.67. The key difference: Revvity Inc pays a 0.26% dividend while YieldMax Magnificent 7 Fund of Option Income ETFs pays none, and Revvity Inc is trading nearer its 52-week high, YieldMax Magnificent 7 Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| RVTY | YMAG | |
|---|---|---|
Market Cap | $11.87B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $117.75 | $15.98 |
52-Week Low | $82.26 | $11.00 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | — |
Trailing returns across standard periods
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →